Interview with Coral Hanson - Edinburgh Napier University (NAPIER)
Coral Hanson
Senior Research Fellow - Edinburgh Napier University (NAPIER)
Could you tell us a bit about yourself?
I graduated from Newcastle Polytechnic in 1991 and received my doctoral degree from Durham University in 2017. I am a senior research fellow in the Centre for Cardiovascular Health at Edinburgh Napier University. My research is focused on understanding the reasons why people do, or do not take part in interventions (such as AF screening).
Could you tell us more about your organization?
Edinburgh Napier University is a modern university in Scotland. We pride ourselves on being an enterprising and innovative community, with more than 300 undergraduate and postgraduate courses and nearly 20,000 students from over 140 countries studying on campus in Edinburgh, online and at partner universities worldwide.
What is your role in the project?
I am a member of the WP 5 team and have been involved in a qualitative study about stakeholder views about AF screening across Europe and a realist review of what works, for whom and why for AF screening.
When did you get involved in AFFECT-EU?
I became involved in AFFECT-EU through my work as part of the Centre for Cardiovascular Health Team working for Professor Lis Neubeck, who is an expert in AF screening.
How did you become interested in AF screening?
Previously I have worked in and undertaken research about cardiac rehabilitation. I became aware that people living with AF were not always eligible for cardiac rehabilitation and from this became interested in screening and lifestyle interventions for AF.
Can you describe your work and how it is related to AFFECT-EU?
I have applied a social science perspective to explore what groups of people access AF screening and the reasons for this, and how this affects screening yield. This has allowed us to develop evidence-based recommendations about how AF screening programmes should plan services to be delivered in locations that are accessible to those most at risk of undiagnosed AF using targeted and inclusive invitations. There is a need to provide training to increase screener understanding of who screen and competence to use digital technology for screening. We have also recommended that organisations should ensure that there are support mechanisms such as automated prompts to increase awareness of who to screen, and that there are standardised follow-up pathways.
How will participation in AFFECT-EU change your professional life?
Participation in AFFECT-EU has widened my professional circle and has allowed me to develop new collaborative partnerships for future work.
Could you tell us a bit about yourself?
I graduated from Newcastle Polytechnic in 1991 and received my doctoral degree from Durham University in 2017. I am a senior research fellow in the Centre for Cardiovascular Health at Edinburgh Napier University. My research is focused on understanding the reasons why people do, or do not take part in interventions (such as AF screening).
Could you tell us more about your organization?
Edinburgh Napier University is a modern university in Scotland. We pride ourselves on being an enterprising and innovative community, with more than 300 undergraduate and postgraduate courses and nearly 20,000 students from over 140 countries studying on campus in Edinburgh, online and at partner universities worldwide.
What is your role in the project?
I am a member of the WP 5 team and have been involved in a qualitative study about stakeholder views about AF screening across Europe and a realist review of what works, for whom and why for AF screening.
When did you get involved in AFFECT-EU?
I became involved in AFFECT-EU through my work as part of the Centre for Cardiovascular Health Team working for Professor Lis Neubeck, who is an expert in AF screening.
How did you become interested in AF screening?
Previously I have worked in and undertaken research about cardiac rehabilitation. I became aware that people living with AF were not always eligible for cardiac rehabilitation and from this became interested in screening and lifestyle interventions for AF.
Can you describe your work and how it is related to AFFECT-EU?
I have applied a social science perspective to explore what groups of people access AF screening and the reasons for this, and how this affects screening yield. This has allowed us to develop evidence-based recommendations about how AF screening programmes should plan services to be delivered in locations that are accessible to those most at risk of undiagnosed AF using targeted and inclusive invitations. There is a need to provide training to increase screener understanding of who screen and competence to use digital technology for screening. We have also recommended that organisations should ensure that there are support mechanisms such as automated prompts to increase awareness of who to screen, and that there are standardised follow-up pathways.
How will participation in AFFECT-EU change your professional life?
Participation in AFFECT-EU has widened my professional circle and has allowed me to develop new collaborative partnerships for future work.
Do you have any predictions for the future of AF screening?
I am confident that AF screening will be used in the future but think it should target those population groups that are most likely to have undiagnosed AF (e.g., those who live in areas of social deprivation or who currently do not engage with primary care). More work is required to understand how best to target these groups.
